Publications by authors named "Andrea Prodosmo"

17Publications

Prognostic role of serum p53 antibodies in lung cancer.

BMC Cancer 2015 Mar 18;15:148. Epub 2015 Mar 18.

Laboratory of Medical Physic and Expert System, Regina Elena National Cancer Institute, via Elio Chianesi 53, 00144, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1174-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374590PMC
March 2015

Mutant cohesin drives chromosomal instability in early colorectal adenomas.

Hum Mol Genet 2014 Dec 30;23(25):6773-8. Epub 2014 Jul 30.

Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Pisa, Italy Istituto Toscano Tumori, Firenze, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddu394DOI Listing
December 2014

ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition.

J Exp Clin Cancer Res 2013 Nov 19;32:95. Epub 2013 Nov 19.

Experimental Oncology, Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-9966-32-95DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176289PMC
November 2013

p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.

J Clin Invest 2013 Mar 1;123(3):1335-42. Epub 2013 Feb 1.

Department of Experimental Oncology, Regina Elena National Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI67289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582149PMC
March 2013

MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.

Mol Cancer Res 2011 Jan 20;9(1):67-77. Epub 2010 Dec 20.

Department of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I, Viale Regina Elena, 324, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-10-0227DOI Listing
January 2011

HIPK2 regulation by MDM2 determines tumor cell response to the p53-reactivating drugs nutlin-3 and RITA.

Cancer Res 2009 Aug 28;69(15):6241-8. Epub 2009 Jul 28.

Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Rome, Italy.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-09-0337DOI Listing
August 2009

HIPKs: Jack of all trades in basic nuclear activities.

Biochim Biophys Acta 2008 Nov 18;1783(11):2124-9. Epub 2008 Jun 18.

Department of Experimental Oncology, Regina Elena Cancer Institute, 00158 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2008.06.006DOI Listing
November 2008

HIPK2: a multitalented partner for transcription factors in DNA damage response and development.

Biochem Cell Biol 2007 Aug;85(4):411-8

Department of Experimental Oncology, Regina Elena Cancer Institute, 00158 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1139/O07-071DOI Listing
August 2007

MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.

Mol Cell 2007 Mar;25(5):739-50

Department of Experimental Oncology, Regina Elena Cancer Institute, Via delle Messi d'Oro 156, 00158 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molcel.2007.02.008DOI Listing
March 2007